Skip to main content
. 2022 May 2;29(1):1326–1334. doi: 10.1080/10717544.2022.2069301

Figure 3.

Figure 3.

Mean ranibizumab release rate in vitro with the PDS 10, 40, or 100 mg/mL. Graph shows mean ranibizumab release rates in vitro in µg/day over a period of 6 months, from PDS implants filled with ranibizumab at 10, 40, or 100 mg/mL. Dashed lines show theoretical drug release curves, calculated based on first-order drug release kinetics. Error bars show SD. Abbreviation: PDS, Port Delivery System with ranibizumab.